NEPH logo

Nephros, Inc. Stock Price

NasdaqCM:NEPH Community·US$51.6m Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 7 Fair Values set on narratives written by author

NEPH Share Price Performance

US$4.85
3.34 (221.19%)
US$6.00
Fair Value
US$4.85
3.34 (221.19%)
19.2% undervalued intrinsic discount
US$6.00
Fair Value
Price US$4.85
AnalystLowTarget US$6.00

NEPH Community Narratives

AnalystLowTarget·
Fair Value US$6 19.2% undervalued intrinsic discount

Hospital Infection Control Challenges May Limit Near-Term Upside Yet Long-Term Potential Appears Intact

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$6
19.2% undervalued intrinsic discount
Revenue
12.01% p.a.
Profit Margin
12.39%
Future PE
26.14x
Price in 2028
US$7.62

Trending Discussion

Updated Narratives

NEPH logo

Hospital Infection Control Challenges May Limit Near-Term Upside Yet Long-Term Potential Appears Intact

Fair Value: US$6 19.2% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet with reasonable growth potential.

2 Risks
3 Rewards

Nephros, Inc. Key Details

US$17.9m

Revenue

US$6.6m

Cost of Revenue

US$11.3m

Gross Profit

US$9.9m

Other Expenses

US$1.5m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
0.14
63.24%
8.26%
0%
View Full Analysis

About NEPH

Founded
1997
Employees
31
CEO
Robert Banks
WebsiteView website
www.nephros.com

Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. It also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, bacteria, cysts, particulates, heavy metals, chemical compounds, scale build-up in downstream equipment, and other various contaminants. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Recent NEPH News & Updates

Nephros (NASDAQ:NEPH) Is Experiencing Growth In Returns On Capital

Dec 13
Nephros (NASDAQ:NEPH) Is Experiencing Growth In Returns On Capital

Recent updates

No updates